Methyl Nonadecanoate

CAS No. 1731-94-8

Methyl Nonadecanoate( Nonadecanoic Acid methyl ester )

Catalog No. M21360 CAS No. 1731-94-8

Methyl Nonadecanoate is a fatty acid methyl ester.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl Nonadecanoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl Nonadecanoate is a fatty acid methyl ester.
  • Description
    Methyl Nonadecanoate is a fatty acid methyl ester.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Nonadecanoic Acid methyl ester
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1731-94-8
  • Formula Weight
    312.5
  • Molecular Formula
    C20H40O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol:63 mg/mL (21.58 mM);DMSO:7 mg/mL (22.39 mM)
  • SMILES
    CCCCCCCCCCCCCCCCCCC(OC)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Evandro P Amanda N Braun J V et al. Development and validation of analytical methodology by GC-FID using hexadecyl propanoate as an internal standard to determine the bovine tallow methyl esters content[J]. Journal of Chromatography B 2018:S1570023218302836-.
molnova catalog
related products
  • Biotinyl-MCH (salmon...

    Biotinyl-MCH (salmon)

  • Neurotensin(8-13) 3T...

    Neurotensin(8-13)(3TFA) is?Neurotensin (NT)?fragment, Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density.The internalization of the receptor induced by neurotensin (8-13) leads to a decrease in the density of the NT1 receptor (NTR1) on the cell surface.

  • Ac2-26 TFA (151988-3...

    Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.